SPYRE INFOSTRUCTURE
Spyre Infostructure is a technology company focused on innovation development.
SPYRE INFOSTRUCTURE
Industry:
Biotechnology Information Technology
Founded:
1996-10-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.spyre.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Font Awesome Facebook Sharer Cloudflare CDN
Similar Organizations
Bontesoft
Bontesoft is a technology company for innovative business development.
Codeister Technologies
Codeister Technologies is a young & vibrant technology company focused on innovative product development in various domains.
DryLab
DryLab is a science and technology company for food dehydration.
Glocalidad
All about technology, science and national innovation will find it here.
Odyssian Technology
Odyssian Technology is a high technology company focused on technology innovation and creative product development.
OFTN
A tech company
PlatforMedia
PlatforMedia is a technology company with a focus on innovation and unique projects.
VetoSynth
VetoSynth is a technology company focused on developing innovative products in the consumer packaged goods space.
Current Employees Featured
Official Site Inspections
http://www.spyre.com Semrush global rank: 3.49 M Semrush visits lastest month: 3.75 K
- Host name: 198.202.211.1
- IP address: 198.202.211.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Spyre Infostructure"
Spyre Therapeutics, Inc. | Investor Relations - Company Overview
2 days ago Spyre Therapeutics is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining best-in-class antibody …See details»
Corporate overview - ir.spyre.com
3. Fully-financed to deliver 7+ Phase 2 proof-of-concept readouts in 2026-27 for the treatment of IBD & beyond. 1. 1. All of the milestones for data including timing are as anticipated or …See details»
Spyre Therapeutics - Crunchbase Company Profile
Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies. ... Experience the new Crunchbase, powered …See details»
Spyre Therapeutics - Leadership Team - The Org
The Leadership Team at Spyre Therapeutics is responsible for setting the strategic direction of the company, ensuring regulatory and legal compliance, overseeing financial health, and …See details»
Spyre Therapeutics (SYRE) Company Profile
Spyre Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD). It develops SPY001, a human monoclonal immunoglobulin G1 antibody …See details»
Spyre Therapeutics - The Org
Spyre Therapeutics combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for inflammatory bowel disease.See details»
Spyre Therapeutics Reports Third Quarter 2024 Financial Results …
Nov 7, 2024 About Spyre Therapeutics Spyre Therapeutics is a clinical-stage biotechnology company that aims to create next-generation of inflammatory bowel disease (IBD) products by …See details»
Spyre Therapeutics
Engineering for new heights in the treatment of Inflammatory Bowel Disease. Spyre Therapeutics is developing potential best-in-class antibodies, rational therapeutic combinations, and …See details»
Spyre Presents Promising SPY001 IBD Data And Combination
2 days ago Dr. Deanna Nguyen, SVP of Clinical Development at Spyre, noted that the extended follow-up data reinforce the potential for SPY001 to offer best-in-class quarterly or biannual …See details»
Spyre Sports - Sports Marketing and Media Agency
Spyre Sports Group is a sports marketing and media agency with over 30 years of marketing experience representing hundreds of professional athletes in various professional sports. Spyre creates NIL opportunities for student-athletes, …See details»
Join Us | Spyre Therapeutics
At Spyre, we are guided by our mission to develop potentially best-in-class therapeutics for people living with IBD. We are a collaborative interdisciplinary team, united in our drive to innovate …See details»
Spyre Therapeutics, Inc.
Apr 1, 2025 Spyre does not undertake or accept any duty to make any updates or revisions to any forward-looking statements. This press release does not purport to summarize all of the …See details»
Spyre Therapeutics - Overview, News & Similar companies
Dec 7, 2023 Spyre Therapeutics Announces $180 Million Private Placement WALTHAM, Mass., Dec. 7, 2023 /PRNewswire/ -- Spyre Therapeutics, Inc. ("Spyre") (NASDAQ: SYRE), a …See details»
About | Spyre Therapeutics
Spyre is focused on developing next generation therapeutics for people living with IBD, including ulcerative colitis (UC) and Crohn’s disease (CD). Our portfolio of novel and proprietary …See details»
Spyre Therapeutics Announces 2025 Priorities and Robust Pipeline
Apr 29, 2025 Spyre Therapeutics, Inc. (NASDAQ: SYRE) has announced its 2025 priorities and a robust pipeline of upcoming clinical readouts, according to a recent press release. The …See details»
Chief Executive Officer - Spyre
Cameron Turtle, DPhil, is Chief Executive Officer. He is an experienced leader in building, financing, and shaping biopharma organizations from preclinical development to late-stage …See details»
Spyre Infostructure - Crunchbase Company Profile & Funding
Spyre Infostructure is a technology company focused on innovation development. View contacts for Spyre Infostructure to access new leads and connect with decision-makers.See details»
Spyre Group | Kansas City's Power BI Leader
Most companies utilize different software and applications for each part of their organization, but they don't always work together or specifcially fit what makes each company or department …See details»
IBM z17: The First Mainframe Fully Engineered for the AI Age
Apr 8, 2025 The Spyre™ Accelerator is specially engineered to bring generative AI capabilities to the mainframe including running assistants, leveraging enterprise data contained in the …See details»
Chief Financial Officer - Spyre
Prior to Spyre, he served as the Chief Financial Officer of Arcutis Biotherapeutics, Inc., where he helped lead Arcutis through a successful initial public offering, several further equity and debt …See details»